Author Correction: Methylprednisolone stimulated gene expression (GILZ, MCL-1) and basal cortisol levels in multiple sclerosis patients in relapse are associated with clinical response (Scientific Reports, (2021), 11, 1, (19462), 10.1038/s41598-021-98868-y)

The original version of this Article contained an error in the order of the References 16 and 17, which was incorrectly given as: 16. Hoepner, R. et al. Vitamin D increases glucocorticoid efficacy via inhibition of mTORC1 in experimental models of multiple sclerosis. Acta Neuropathol. https:// doi. org/ 10. 1007/ s00401- 019- 02018-8 (2019). 17. Ayroldi E, Riccardi C. Glucocorticoid‐induced leucine zipper (GILZ): a new important mediator of glucocorticoid action. FASEB J 23, 3649–3658 (2009). The correct order of the References is listed below: 16. Ayroldi E, Riccardi C. Glucocorticoid‐induced leucine zipper (GILZ): a new important mediator of glucocorticoid action. FASEB J 23, 3649–3658 (2009). 17. Hoepner, R. et al. Vitamin D increases glucocorticoid efficacy via inhibition of mTORC1 in experimental models of multiple sclerosis. Acta Neuropathol. https:// doi. org/ 10. 1007/ s00401- 019- 02018-8 (2019). The original Article has been corrected. © 2021, The Author(s).